Additionally, fewer effector CD8+ T cells and increased LGALS1-CXCR4/CD69 and TGFB1-CXCR4 interactions between tumor cells and other TMEs are linked to ibrutinib resistance.35 This evidence concerns the gene CD8A and neoplasm.